neurodegenerative disease: A disorder of the central nervous system characterized by gradual and progressive loss of neural tissue and neurologic function.
Senile degeneration of the brain, not elsewhere classified
DOID EFO Endpoint Browser PheWeb
G6_DEGENSEN
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
154 |
4. Check minimum number of eventsNone |
154 |
5. Include endpointsNone |
154 |
6. Filter based on genotype QC (FinnGen only) |
150 |
Control definitions (FinnGen only)
- Control exclude
- G6_NEURODEG
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF6
- Parent code in ICD-10
- G31
- Name in latin
- Degeneratio cerebri senilis non alibi classificata
Similar endpoints
↥List of similar endpoints to
Senile degeneration of the brain, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Degenerative diseases of the nervous system
- Other degenerative diseases of the nervous system
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3797 | 1926 | 1743 |
| Only index persons | 1467 | 804 | 663 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.05 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 75.25 | 76.87 | 73.64 |
| Only index persons | 76.36 | 78.22 | 74.12 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 150 | 55 | 95 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.04 |
| Median age at first event (years) | 73.28 | 73.57 | 73.12 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 153
- Matched controls
- 1529
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
+∞
154.5
121
*
N06DX01
ATC
memantine; oral
15.3
42.3
42
37
F03
ICD-10 Finland
Unspecified dementia
13.1
42.0
47
50
N06DA02
ATC
donepezil; oral
15.9
35.2
33
26
G30.1
ICD-10 Finland
Alzheimer disease with late onset
35.7
28.2
36
13
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
37.7
26.3
33
11
3312X
ICD-9 Finland
Other cerebral degenerations, Senile degeneration of brain
+∞
25.7
24
*
N05AX08
ATC
risperidone; systemic
7.6
24.0
40
68
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
76.0
18.2
20
*
G31.0
ICD-10 Finland
Circumscribed brain atrophy
165.0
14.7
15
*
N05AH04
ATC
quetiapine; oral
4.2
11.7
37
108
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.4
11.0
31
83
N06DA03
ATC
rivastigmine; oral, transdermal
9.5
10.5
21
25
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.9
10.4
20
38
P20
ICPC
Memory disturbance
3.6
10.2
42
147
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
32.3
9.5
12
*
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
+∞
9.5
9
*
N05BA06
ATC
lorazepam; systemic, sublingual
5.4
9.1
19
39
G30.8
ICD-10 Finland
Other Alzheimer disease
21.5
8.6
12
6
N03AG01
ATC
valproic acid; systemic, rectal
7.2
7.4
17
26
F0019, G301,
ICD-10 Finland
+∞
7.3
7
*
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
+∞
7.3
7
*
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
31.6
7.2
9
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.8
6.5
21
61
G30.0
ICD-10 Finland
Alzheimer disease with early onset
+∞
6.3
6
*
N05AH03
ATC
olanzapine; systemic
8.2
6.3
13
17
N05BA01
ATC
diazepam; systemic, rectal
3.0
6.1
30
115
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
16
39
4.46
6.25
1.3
1.3
—
—
—
0
0
24
86
3.12
5.43
1.7
1.6
—
—
—
0
0
43
244
2.06
3.66
2.5
1.8
1222.84
1227.93
nmol/l
0.01
32
193
5
5
10.27
3.00
1.2
1.0
1.77
1.95
mmol/l
—
5
5
67
842
0.64
2.01
8.0
6.9
42.42
42.08
mmol/mol
0.08
60
767
6
18
3.42
1.76
3.2
3.3
63.33
61.83
%
—
6
18
69
844
0.67
1.68
4.5
4.9
1.41
1.42
mmol/l
0.07
58
740
67
823
0.67
1.65
4.3
4.4
1.33
1.23
mmol/l
0.40
55
718
70
848
0.68
1.57
4.4
4.9
4.52
4.33
mmol/l
0.78
57
756
74
879
0.69
1.43
5.1
5.2
5.75
6.16
mmol/l
1.51
68
765
74
878
0.69
1.41
4.9
5.5
2.70
2.48
mmol/l
1.32
63
771
72
853
0.70
1.33
22.8
18.2
69.32
69.67
ml/min/173m2
0.04
57
693
11
55
2.08
1.30
2.3
2.3
9.18
6.48
ug/l
0.10
11
46
84
967
0.71
1.29
38.8
26.7
36.41
38.71
%
1.22
72
907
20
124
1.70
1.28
2.0
1.8
—
—
—
0
0
23
334
0.63
1.20
5.4
3.7
10.11
13.09
mg/mmol
0.17
17
221
14
80
1.82
1.17
1.5
1.4
—
—
—
0
0
5
21
2.42
1.10
2.2
1.5
—
—
—
0
0
82
934
0.74
1.07
30.2
22.0
96.99
89.38
umol/l
0.34
82
934
55
445
1.37
1.03
2.3
2.1
92.83
91.10
pmol/l
0.06
25
221
26
183
1.51
1.02
2.0
1.9
—
—
—
0
0
17
250
0.64
0.94
2.5
3.3
0.75
0.79
ug/l
0.10
11
170
19
127
1.57
0.94
2.1
1.8
—
—
—
0
0
25
182
1.45
0.84
2.6
2.3
2.22
2.23
g/l
0.03
20
159
27
353
0.71
0.82
4.4
4.6
20.94
22.03
%
0.17
14
193
5
23
2.21
0.77
1.6
2.6
—
—
—
0
0
26
196
1.39
0.74
2.7
2.3
10.40
11.93
umol/l
0.54
21
174
11
68
1.66
0.73
2.1
1.8
—
—
—
0
0
7
39
1.83
0.73
1.1
1.5
—
—
—
0
0
43
354
1.30
0.69
3.1
2.8
2.34
2.34
mmol/l
0.04
35
306
38
310
1.30
0.66
2.7
2.1
2.64
3.25
mg/l
1.02
31
269
33
264
1.32
0.65
1.6
1.6
22.35
20.81
nmol/l
0.20
27
207
58
501
1.25
0.64
3.8
3.2
53.38
59.79
u/l
0.32
50
453
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
46
532
0.81
0.56
6.3
8.4
5.58
4.35
e9/l
1.55
40
451
83
904
0.82
0.55
29.4
18.6
32.90
27.85
mg/l
0.55
71
766
10
66
1.55
0.54
3.6
5.7
22.10
24.26
mmol/l
—
10
66
7
45
1.58
0.49
1.6
1.9
—
—
—
0
0
59
523
1.21
0.49
10.1
6.2
1.21
1.21
mmol/l
0.17
50
434
7
49
1.45
0.46
1.6
2.0
—
—
—
0
0
54
479
1.20
0.44
6.1
4.3
0.00
0.00
estimate
-0.00
13
108
5
31
1.63
0.43
1.2
1.5
—
—
—
0
0
39
447
0.83
0.42
6.1
5.6
3.41
3.17
ug/l
0.07
34
379
51
452
1.19
0.42
3.6
2.4
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
54
483
1.18
0.40
6.1
4.3
0.00
0.00
estimate
-0.00
11
94
53
478
1.17
0.35
8.7
5.9
0.00
0.00
estimate
-0.00
11
98
53
478
1.17
0.35
9.5
5.9
1.21
1.21
mmol/l
0.17
47
425
21
173
1.25
0.35
2.9
2.3
26.64
21.15
%
0.41
13
150
18
146
1.26
0.34
5.5
5.8
105.67
104.12
mmol/l
0.82
18
146
71
762
0.87
0.33
7.9
7.1
77.90
81.92
u/l
0.52
63
703
34
297
1.19
0.33
4.9
3.4
0.94
0.54
e6/l
0.30
28
230
7
52
1.36
0.31
3.0
3.9
24.56
24.76
mmol/l
—
7
47
75
800
0.88
0.31
6.1
4.6
2.08
2.10
mu/l
0.04
64
679
43
387
1.15
0.29
5.5
3.4
—
—
—
0
0
27
235
1.18
0.27
2.8
2.3
—
—
—
0
0
9
73
1.25
0.26
3.2
3.1
0.03
0.36
e6/l
—
9
73
24
209
1.18
0.24
6.9
4.6
1.01
1.02
kg/l
—
10
27
30
267
1.15
0.24
2.3
1.8
538.75
449.07
pmol/l
0.39
24
227
5
38
1.33
0.23
2.0
3.1
—
—
—
0
0
7
92
0.75
0.23
7.6
4.5
1.22
1.21
mmol/l
—
7
82
5
39
1.29
0.23
1.4
5.1
—
3.93
—
0
6
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
11.33
—
0
12
0
13
0.00
0.21
0.0
1.4
—
342.62
—
0
13
0
13
0.00
0.21
0.0
1.7
—
15.38
—
0
13
41
377
1.12
0.20
7.0
4.6
—
—
—
0
0
24
214
1.14
0.19
2.8
2.7
2.48
2.47
mmol/l
0.05
18
188
6
75
0.79
0.16
1.3
1.4
—
—
—
0
0
43
402
1.10
0.16
2.6
2.2
—
—
—
0
0
19
170
1.13
0.14
3.4
3.0
0.95
2.00
e6/l
0.72
11
95
26
282
0.91
0.13
7.0
4.2
0.00
0.00
estimate
—
8
94
50
475
1.08
0.13
5.5
4.7
39.91
64.96
ng/l
1.03
41
378
11
97
1.14
0.09
2.6
3.0
120.98
348.49
ng/l
2.63
11
86
19
175
1.10
0.09
2.8
2.8
1.94
1.02
e6/l
0.21
11
99
58
564
1.04
0.06
24.2
19.7
1.20
1.44
inr
1.15
15
168
40
387
1.04
0.05
3.6
2.6
166.00
137.30
ug/l
0.39
33
341
67
682
0.97
0.04
4.4
4.4
15.34
15.94
mm/h
0.13
59
610
64
647
0.98
0.01
4.8
3.6
14.85
15.02
pmol/l
0.14
55
552
39
384
1.02
0.00
2.3
2.3
86.38
77.17
nmol/l
0.83
33
324
13
133
0.97
0.00
10.2
9.2
—
—
—
0
0
12
121
0.99
0.00
4.5
4.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
98.50
—
0
8
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
8.57
—
0
7
0
6
0.00
-0.00
0.0
1.3
—
1.28
—
0
6
0
6
0.00
-0.00
0.0
7.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
100.33
—
0
6
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
38.37
—
0
6
0
6
0.00
-0.00
0.0
4.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
17.50
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_DEGENSEN and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_DEGENSEN | 2.462 [2.03, 2.98] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.078 |
During the follow-up period (1.1.1998 — 31.12.2019), 693 out of 897 females with G6_DEGENSEN died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_DEGENSEN | 2.829 [2.17, 3.68] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 543 out of 705 males with G6_DEGENSEN died.
Mortality risk
Mortality risk for people of age
years, who have G6_DEGENSEN.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.186% | 0.6% |
| 5 | 1.292% | 3.795% |
| 10 | 3.155% | 8.592% |
| 15 | 6.112% | 15.646% |
| 20 | 10.464% | 25.722% |
Relationships between endpoints
↥Index endpoint: G6_DEGENSEN – Senile degeneration of the brain, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data